Author:
Haas Cameron B.,Su Yu-Ru,Petersen Paneen,Wang Xiaoliang,Bien Stephanie A.,Lin Yi,Albanes Demetrius,Weinstein Stephanie J.,Jenkins Mark A.,Figueiredo Jane C.,Newcomb Polly A.,Casey Graham,Le Marchand Loic,Campbell Peter T.,Moreno Victor,Potter John D.,Sakoda Lori C.,Slattery Martha L.,Chan Andrew T.,Li Li,Giles Graham G.,Milne Roger L.,Gruber Stephen B.,Rennert Gad,Woods Michael O.,Gallinger Steven J.,Berndt Sonja,Hayes Richard B.,Huang Wen-Yi,Wolk Alicja,White Emily,Nan Hongmei,Nassir Rami,Lindor Noralane M.,Lewinger Juan P.,Kim Andre E.,Conti David,Gauderman W. James,Buchanan Daniel D.,Peters Ulrike,Hsu Li
Abstract
AbstractObservational studies have shown higher folate consumption to be associated with lower risk of colorectal cancer (CRC). Understanding whether and how genetic risk factors interact with folate could further elucidate the underlying mechanism. Aggregating functionally relevant genetic variants in set-based variant testing has higher power to detect gene–environment (G × E) interactions and may provide information on the underlying biological pathway. We investigated interactions between folate consumption and predicted gene expression on colorectal cancer risk across the genome. We used variant weights from the PrediXcan models of colon tissue-specific gene expression as a priori variant information for a set-based G × E approach. We harmonized total folate intake (mcg/day) based on dietary intake and supplemental use across cohort and case–control studies and calculated sex and study specific quantiles. Analyses were performed using a mixed effects score tests for interactions between folate and genetically predicted expression of 4839 genes with available genetically predicted expression. We pooled results across 23 studies for a total of 13,498 cases with colorectal tumors and 13,918 controls of European ancestry. We used a false discovery rate of 0.2 to identify genes with suggestive evidence of an interaction. We found suggestive evidence of interaction with folate intake on CRC risk for genes including glutathione S-Transferase Alpha 1 (GSTA1; p = 4.3E−4), Tonsuko Like, DNA Repair Protein (TONSL; p = 4.3E−4), and Aspartylglucosaminidase (AGA: p = 4.5E−4). We identified three genes involved in preventing or repairing DNA damage that may interact with folate consumption to alter CRC risk. Glutathione is an antioxidant, preventing cellular damage and is a downstream metabolite of homocysteine and metabolized by GSTA1. TONSL is part of a complex that functions in the recovery of double strand breaks and AGA plays a role in lysosomal breakdown of glycoprotein.
Funder
National Institutes of Health
National Institutes of Health,United States
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist, 8781–8807 (1996).
2. Crider, K. S. et al. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349, g4554 (2014).
3. Choumenkovitch, S. F. et al. Folic acid intake from fortification in United States exceeds predictions. J. Nutr. 132, 2792–2798 (2002).
4. Finglas, P. M. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. https://doi.org/10.1016/S0924-2244(01)00010-3 (2000).
5. Initiative FF. FFI—Global Progress. http://ffinetwork.org/global_progress/index.php (Accessed 7 Dec2017).